Subscribe to Treatment of T2DM Patients in Germany receiving Empagliflozin: A retrospective RWE Study Description of Treatment and Population Characteristics of Type 2 Diabetic Patients in Germany receiving Empagliflozin: A retrospective Real-World Evidence (RWE) study based on German registries DPV&DIVE